NCT05247684 2026-03-05AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLCAkesoPhase 2 Active not recruiting90 enrolled
NCT06161441 2026-01-12A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With SurgeryRegeneron PharmaceuticalsPhase 2 Active not recruiting195 enrolled